The relationship between depressive symptoms and subjective well-being in newly admitted patients with schizophrenia

被引:18
作者
Kim, Jong-Hoon [1 ]
Ann, Jun-Hyung [1 ]
Kim, Min-Jung [1 ]
机构
[1] Gachon Univ Med & Sci, Dept Psychiat, Gil Med Ctr, Inchon 405760, South Korea
关键词
QUALITY-OF-LIFE; ANTIPSYCHOTIC-DRUG-THERAPY; DOUBLE-BLIND; FOLLOW-UP; SCALE; OLANZAPINE; PSYCHOPATHOLOGY; EXPERIENCE; CLOZAPINE; DEFICITS;
D O I
10.1016/j.comppsych.2009.05.004
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Depressive symptoms are common in schizophrenia and are considered core features of the disorder. The purpose of the present study was to examine the relationship between depressive symptoms and subjective well-being in newly admitted patients with schizophrenia. Methods: Eighty newly admitted patients were comprehensively evaluated for subjective well-being, schizophrenic symptoms, and depressive symptoms using the Subjective Well-Being Under Neuroleptics Scale (SWN), the Positive and Negative Syndrome Scale (PANSS), and the Beck Depression Inventory. Correlation coefficients were obtained between depressive symptoms and subjective wellbeing while controlling for the influence of the severity of psychotic symptoms, extrapyramidal side effect, and subjective attitude toward antipsychotics, as assessed by the PANSS, the Drug-Induced Extrapyramidal Symptoms Scale, and the Drug Attitude Inventory, respectively. Results: The SWN score had a significant negative correlation with the PANSS depression factor score (P < 001). Correlation analysis also revealed a significant negative correlation between the SWN score and the Beck Depression Inventory score (P < .001). Conclusions: The results of our study suggest that depressive symptoms are significantly associated with a low subjective well-being in newly admitted patients with schizophrenia and that the relationship is significant even after controlling for the influence of potential confounding variables. Detection and appropriate management of depressive symptoms in schizophrenic patients may affect their perceptions of their own well-being. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:165 / 170
页数:6
相关论文
共 65 条
  • [1] ASSESSING DEPRESSION IN SCHIZOPHRENIA - THE CALGARY DEPRESSION SCALE
    ADDINGTON, D
    ADDINGTON, J
    MATICKATYNDALE, E
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1993, 163 : 39 - 44
  • [2] SPECIFICITY OF THE CALGARY-DEPRESSION-SCALE FOR SCHIZOPHRENICS
    ADDINGTON, D
    ADDINGTON, J
    MATICKATYNDALE, E
    [J]. SCHIZOPHRENIA RESEARCH, 1994, 11 (03) : 239 - 244
  • [3] [Anonymous], 2000, J KOREAN NEUROPSYCHI
  • [4] AZORIN JM, 1995, ACTA PSYCHIAT SCAND, V91, P20
  • [5] Beck A.T., 1967, Depression: Clinical, experimental, and theoretical aspects
  • [6] AN INVENTORY FOR MEASURING DEPRESSION
    BECK, AT
    ERBAUGH, J
    WARD, CH
    MOCK, J
    MENDELSOHN, M
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) : 561 - &
  • [7] 5-COMPONENT MODEL OF SCHIZOPHRENIA - ASSESSING THE FACTORIAL INVARIANCE OF THE POSITIVE AND NEGATIVE SYNDROME SCALE
    BELL, MD
    LYSAKER, PH
    BEAMGOULET, JL
    MILSTEIN, RM
    LINDENMAYER, JP
    [J]. PSYCHIATRY RESEARCH, 1994, 52 (03) : 295 - 303
  • [8] At issue: Hierarchical diagnosis in chronic schizophrenia: A clinical study of co-occurring syndromes
    Bermanzohn, PC
    Porto, L
    Arlow, PB
    Pollack, S
    Stronger, R
    Siris, SG
    [J]. SCHIZOPHRENIA BULLETIN, 2000, 26 (03) : 517 - 525
  • [9] Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: A 6-week placebo-controlled trial
    Daniel, DG
    Zimbroff, DL
    Potkin, SG
    Reeves, KR
    Harrigan, EP
    Lakshminarayanan, M
    [J]. NEUROPSYCHOPHARMACOLOGY, 1999, 20 (05) : 491 - 505
  • [10] Improvement of subjective well-being and enduring symptomatic remission, A 5-year follow-up of first episode schizophrenia
    de Haan, L.
    van Nimwegen, L.
    van Amelsvoort, T.
    Dingemans, P.
    Linszen, D.
    [J]. PHARMACOPSYCHIATRY, 2008, 41 (04) : 125 - 128